HB 712: AG; AFFORDABLE HEALTH CARE; PRESCRIPTION DRUGS; 340B DRUG PRICING PROGRAM; PHARMACIES; COVERED ENTITIES; DISCRIMINATORY PRACTICES; REPORTS

Prohibits drug manufacturers from denying, restricting, or prohibiting the acquisition, shipping, or delivery of a 340B drug to pharmacies contracted with 340B covered entities under the federal 340B Drug Pricing Program.  Authorizes 340B covered entities and the Attorney General to bring a civil action for enforcement within four years of a violation.  Beginning 7/1/2026, requires each 340B covered entity in the State to report certain information annually to the hospital trade association operating in the State and requires the hospital trade association to prepare and publicly post an aggregate report of reports submitted by each 340B covered entity.  (CD1)